Monday, April 27
6:30 pm - 8:30 pm
Location: Back Bay; Ocean Prime
Advanced Practice Provider Fee: $195
Candidate and Medical Student Fee: $195
Moderator(s): Constantinos G. Hadjipanayis, MD, PhD, FAANS
Faculty: Shawn Level Hervey-Jumper, MD, FAANS; John Y.K. Lee, MD, FAANS; Peter Nakaji, MD, FAANS; Nader Sanai, MD, FAANS; Walter Stummer, MD (Germany); Georg Widhalm, MD, PhD, IFAANS (Austria)
This symposium is an introduction to fluorescence-guided surgery (FGS) of brain tumors to practicing neurosurgeons. With the recent US FDA approval of 5-ALA FGS for glioma surgery in 2017, neurosurgeons are incorporating this important new technology into their practices in the U.S. Experts from both the US and Europe review for attendees the current state of FGS for brain tumors and the use of 5-ALA and other fluorophores for brain tumor removal. Attend to better understand how to safely incorporate FGS into practice and learn about the FGS pitfalls and pearls. Presentations also incorporate new approaches with FGS for brain tumors and new technologies with visualization devices that advance FGS for brain tumors.
Ocean Prime Boston
Ocean Prime Boston is located in the new 100 Pier 4 building in Boston’s bustling Seaport District. A modern American restaurant and lounge, Ocean Prime delivers an extraordinary experience with a stunning setting, an impressive menu of seafood and prime cuts of steak, signature cocktails, a Wine Spectator-honored wine list and truly genuine hospitality. From the kitchen and bar, there is an appreciation for ingredients that comes through in every dish. The menu is both classic and modern, featuring lighter items, like sushi and poke, and indulgent seafood presentations, juicy steaks and decadent desserts.
Learning Objectives: After completing this educational activity, participants should be able to:
- Review the pearls and pitfalls to (FGS) of brain tumors.
- Safely implement (FGS) of brain tumors into a neurosurgical practice.
- Identify the latest visualization technologies being used for (FGS) of brain tumors and potential new fluorophores that could be used in the future for (FGS).